CRISPR-Cas9 (N-Term) antibody
Quick Overview for CRISPR-Cas9 (N-Term) antibody (ABIN7278752)
Target
Reactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Binding Specificity
- N-Term
-
Purpose
- CRISPR/Cas9 Monoclonal Antibody [7A9-3A3]-0.1ml / BSA/Azide-Free
-
Purification
- Protein A
-
Immunogen
- This antibody was raised against a recombinant protein within the N-terminal region of Streptococcus pyogene Cas9
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
- Optimal antibody dilution should be determined by titration, however as a guideline try at,IB 0.1-1 μg/mL
-
Comment
-
Myeloma/fusion partners:X63.Ag8-653
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Purified antibody in PBS. Does not contain sodium azide or BSA
-
Preservative
- Azide free
-
-
- CRISPR-Cas9
-
Alternative Name
- CRISPR/Cas9
-
Background
- Cas9 antibodyCRISPR-associated endonuclease Cas9/Csn1 antibodyCRISPR-Cas9/Csn1 antibodycsn1 antibodySpyCas9 antibody
-
Gene ID
- 901176
Target
-